Trials / Completed
CompletedNCT01406119
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
An Extension Study of ABT-806 for Subjects With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This is an extension study of ABT-806 for subjects with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-806 | ABT-806 will be administered by intravenous infusion. |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2011-08-01
- Last updated
- 2017-01-27
Locations
4 sites across 2 countries: United States, Australia
Source: ClinicalTrials.gov record NCT01406119. Inclusion in this directory is not an endorsement.